Growth Metrics

Electromed (ELMD) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Electromed 300.53 Mn 283.55 Mn 14.64 Mn -205.48%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -205.48%
Dec 31, 2025 -176.79%
Sep 30, 2025 -360.34%
Jun 30, 2025 -241.30%
Mar 31, 2025 213.18%
Dec 31, 2024 -172.41%
Sep 30, 2024 56.39%
Jun 30, 2024 89.57%
Mar 31, 2024 76.88%
Dec 31, 2023 81.13%
Sep 30, 2023 48.05%
Jun 30, 2023 3.92%
Mar 31, 2023 -14.81%
Dec 31, 2022 -48.71%
Sep 30, 2022 5.19%
Jun 30, 2022 -91.25%
Mar 31, 2022 -659.38%
Dec 31, 2021 -400.00%
Sep 30, 2021 -229.27%
Jun 30, 2021 -89.48%
Mar 31, 2021 57.22%
Dec 31, 2020 78.27%
Sep 30, 2020 80.26%
Jun 30, 2020 88.95%
Mar 31, 2020 -66.91%
Dec 31, 2019 -139.88%
Sep 30, 2019 -1,189.71%
Jun 30, 2019 -596.03%
Mar 31, 2019 46.95%
Dec 31, 2018 12.41%
Sep 30, 2018 68.55%
Jun 30, 2018 18.17%
Mar 31, 2018 3.10%
Dec 31, 2017 43.59%
Sep 30, 2017 -44.38%
Jun 30, 2017 31.80%
Mar 31, 2017 -103.95%
Dec 31, 2016 -185.69%
Sep 30, 2016 38.21%
Jun 30, 2016 -20.44%
Mar 31, 2016 -99.83%
Dec 31, 2015 50.69%
Sep 30, 2015 30.82%
Jun 30, 2015 19.93%
Mar 31, 2015 87.46%
Dec 31, 2014 -18.35%
Sep 30, 2014 -11.47%
Jun 30, 2014 1.53%
Mar 31, 2014 -46.72%
Dec 31, 2013 49.55%
Sep 30, 2013 33.55%
Jun 30, 2013 -255.33%
Mar 31, 2013 -94.25%
Dec 31, 2012 29.28%
Sep 30, 2012 5.47%
Jun 30, 2012 40.39%
Mar 31, 2012 -11.68%
Dec 31, 2011 28.14%
Sep 30, 2011 19.33%